Liu P, Zhou Q, Li J
Front Oncol. 2022; 12:913432.
PMID: 35814473
PMC: 9259879.
DOI: 10.3389/fonc.2022.913432.
Brzuska G, Pastuch-Gawolek G, Krawczyk M, Szewczyk B, Krol E
Pharmaceuticals (Basel). 2020; 13(12).
PMID: 33322151
PMC: 7764612.
DOI: 10.3390/ph13120460.
Madec A, Schocker N, Sanchini S, Myratgeldiyev G, Das D, Imperiali B
ACS Chem Biol. 2018; 13(9):2542-2550.
PMID: 30080379
PMC: 6457116.
DOI: 10.1021/acschembio.8b00477.
Chen N, Xie J
Molecules. 2018; 23(3).
PMID: 29534554
PMC: 6017822.
DOI: 10.3390/molecules23030641.
Malkowski S, Dishuck C, Lamanilao G, Embry C, Grubb C, Cafiero M
Molecules. 2017; 22(10).
PMID: 28994722
PMC: 6151744.
DOI: 10.3390/molecules22101682.
Hydroxybenzaldoximes Are D-GAP-Competitive Inhibitors of E. coli 1-Deoxy-D-Xylulose-5-Phosphate Synthase.
Bartee D, Morris F, Al-Khouja A, Freel Meyers C
Chembiochem. 2015; 16(12):1771-81.
PMID: 26174207
PMC: 4609000.
DOI: 10.1002/cbic.201500119.
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.
Vasconcelos-Dos-Santos A, Oliveira I, Lucena M, Mantuano N, Whelan S, Dias W
Front Oncol. 2015; 5:138.
PMID: 26161361
PMC: 4479729.
DOI: 10.3389/fonc.2015.00138.
Parallel solution-phase synthesis and general biological activity of a uridine antibiotic analog library.
Moukha-Chafiq O, Reynolds R
ACS Comb Sci. 2014; 16(5):232-7.
PMID: 24661222
PMC: 4025591.
DOI: 10.1021/co4001452.
The endoplasmic reticulum-resident chaperone heat shock protein 47 protects the Golgi apparatus from the effects of O-glycosylation inhibition.
Miyata S, Mizuno T, Koyama Y, Katayama T, Tohyama M
PLoS One. 2013; 8(7):e69732.
PMID: 23922785
PMC: 3726774.
DOI: 10.1371/journal.pone.0069732.
Parallel solution-phase synthesis of an adenosine antibiotic analog library.
Moukha-Chafiq O, Reynolds R
ACS Comb Sci. 2013; 15(3):147-52.
PMID: 23398694
PMC: 3652606.
DOI: 10.1021/co300127z.
Nine enzymes are required for assembly of the pacidamycin group of peptidyl nucleoside antibiotics.
Zhang W, Ntai I, Bolla M, Malcolmson S, Kahne D, Kelleher N
J Am Chem Soc. 2011; 133(14):5240-3.
PMID: 21417270
PMC: 3071879.
DOI: 10.1021/ja2011109.
Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics.
Trunkfield A, Gurcha S, Besra G, Bugg T
Bioorg Med Chem. 2010; 18(7):2651-63.
PMID: 20226679
PMC: 3034214.
DOI: 10.1016/j.bmc.2010.02.026.
Reconstruction of metabolic pathways for the cattle genome.
Seo S, Lewin H
BMC Syst Biol. 2009; 3:33.
PMID: 19284618
PMC: 2669051.
DOI: 10.1186/1752-0509-3-33.
Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase.
Williams A, Raetz C
Proc Natl Acad Sci U S A. 2007; 104(34):13543-50.
PMID: 17698807
PMC: 1959417.
DOI: 10.1073/pnas.0705833104.
Uracil-directed ligand tethering: an efficient strategy for uracil DNA glycosylase (UNG) inhibitor development.
Jiang Y, Krosky D, Seiple L, Stivers J
J Am Chem Soc. 2005; 127(49):17412-20.
PMID: 16332091
PMC: 2522323.
DOI: 10.1021/ja055846n.
Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation.
Becker S, Palsson B
BMC Microbiol. 2005; 5:8.
PMID: 15752426
PMC: 1079855.
DOI: 10.1186/1471-2180-5-8.
Towards a better understanding of the substrate specificity of the UDP-N-acetylglucosamine C4 epimerase WbpP.
Demendi M, Ishiyama N, Lam J, Berghuis A, Creuzenet C
Biochem J. 2005; 389(Pt 1):173-80.
PMID: 15752069
PMC: 1184549.
DOI: 10.1042/BJ20050263.
Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library.
Scherman M, Winans K, Stern R, Jones V, Bertozzi C, McNeil M
Antimicrob Agents Chemother. 2002; 47(1):378-82.
PMID: 12499218
PMC: 148999.
DOI: 10.1128/AAC.47.1.378-382.2003.